Inhibition of Aberrant α(1,2)-Fucosylation at Ocular Surface Ameliorates Dry Eye Disease

• Published in: International journal of molecular sciences Vol. 22; no. 15; p. 7863
• Main Authors: Yoon, Chang Ho, Ryu, Jin Suk, Ko, Jung Hwa, Oh, Joo Youn
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.08.2021; MDPI
• Subjects: 2-deoxy-D-galactose; Animal models; Antigens; Biological activity; CD4 antigen; Cell adhesion; Conjunctiva; Cornea; Cytokines; D-Galactose; dry eye disease; Exocrine glands; Eye diseases; fucosylation; Galactose; Glycan; glycosylation; Goblet cells; H antigen; Homeostasis; Immunoregulation; Inflammation; Lymph nodes; ocular surface; Pathogenesis; Polysaccharides; Rheumatoid arthritis; Two dimensional models; γ-Interferon
• DOI: 10.3390/ijms22157863
• ISSN: 1422-0067; 1661-6596

Fucosylation is involved in a wide range of biological processes from cellular adhesion to immune regulation. Although the upregulation of fucosylated glycans was reported in diseased corneas, its implication in ocular surface disorders remains largely unknown. In this study, we analyzed the expression of a fucosylated glycan on the ocular surface in two mouse models of dry eye disease (DED), the NOD.B10.H2b mouse model and the environmental desiccating stress model. We furthermore investigated the effects of aberrant fucosylation inhibition on the ocular surface and DED. Results demonstrated that the level of type 2 H antigen, an α(1,2)-fucosylated glycan, was highly increased in the cornea and conjunctiva both in NOD.B10.H2b mice and in BALB/c mice subjected to desiccating stress. Inhibition of α(1,2)-fucosylation by 2-deoxy-D-galactose (2-D-gal) reduced corneal epithelial defects and increased tear production in both DED models. Moreover, 2-D-gal treatment suppressed the levels of inflammatory cytokines in the ocular surface and the percentages of IFN-γ+CD4+ cells in draining lymph nodes, whereas it did not affect the number of conjunctival goblet cells, the MUC5AC level or the meibomian gland area. Together, the findings indicate that aberrant fucosylation underlies the pathogenesis of DED and may be a novel target for DED therapy.